Filed: 8/14/2026ACC: 0001072613-26-000684
📋 What this filing means
NEA MANAGEMENT COMPANY, LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $1.59B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$1.59B
Total AUM (reported)
111.75M
Total Shares
Allocation by class
COM$1.34B84.1%
COM SHS$164.55M10.4%
NAMEN AKT$57.73M3.6%
COM NEW$22.73M1.4%
ADS$5.53M0.3%
COM CL A$2.18M0.1%
Portfolio Concentration
Top 3$632.27M39.8%
4–10$794.04M50.0%
11–25$161.46M10.2%
Rest$164.6K0.0%
Top 3 weight
39.8%
Top 10 weight
89.8%
Voting Authority Distribution
Total shares with voting rights: 111.75M
Sole
Full voting authority
111.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other26
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
Trevi Therapeutics, Inc.
DFNDShares13.22M
TypeSH
Market value$246.59M
15.53%
Sole
13.22M
Shared
0.00
None
0.00
MBX Biosciences, Inc.
DFNDShares3.61M
TypeSH
Market value$199.52M
12.56%
Sole
3.61M
Shared
0.00
None
0.00
Monte Rosa Therapeutics, Inc.
DFNDShares7.69M
TypeSH
Market value$186.15M
11.72%
Sole
7.69M
Shared
0.00
None
0.00
Celcuity Inc.
DFNDShares1.71M
TypeSH
Market value$178.96M
11.27%
Sole
1.71M
Shared
0.00
None
0.00
Spyglass Pharma, Inc.
DFNDShares7.39M
TypeSH
Market value$164.55M
10.36%
Sole
7.39M
Shared
0.00
None
0.00
Savara, Inc.
DFNDShares24.47M
TypeSH
Market value$150.74M
9.49%
Sole
24.47M
Shared
0.00
None
0.00
Zenas BioPharma, Inc.
DFNDShares4.02M
TypeSH
Market value$102.11M
6.43%
Sole
4.02M
Shared
0.00
None
0.00
Coursera, Inc.
DFNDShares12.87M
TypeSH
Market value$72.57M
4.57%
Sole
12.87M
Shared
0.00
None
0.00
Aurinia Pharmaceuticals, Inc.
DFNDShares3.97M
TypeSH
Market value$67.37M
4.24%
Sole
3.97M
Shared
0.00
None
0.00
CRISPR Therapeutics AG
DFNDShares1.06M
TypeSH
Market value$57.73M
3.64%
Sole
1.06M
Shared
0.00
None
0.00
ORIC Pharmaceuticals, Inc.
DFNDShares4.12M
TypeSH
Market value$44.60M
2.81%
Sole
4.12M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
DFNDShares1.96M
TypeSH
Market value$21.27M
1.34%
Sole
1.96M
Shared
0.00
None
0.00
Korro Bio, Inc.
DFNDShares1.30M
TypeSH
Market value$17.11M
1.08%
Sole
1.30M
Shared
0.00
None
0.00
X4 Pharmaceuticals, Inc.
DFNDShares3.23M
TypeSH
Market value$15.10M
0.95%
Sole
3.23M
Shared
0.00
None
0.00
Champions Oncology, Inc.
DFNDShares1.71M
TypeSH
Market value$10.56M
0.66%
Sole
1.71M
Shared
0.00
None
0.00
Nkarta, Inc.
DFNDShares3.57M
TypeSH
Market value$10.10M
0.64%
Sole
3.57M
Shared
0.00
None
0.00
CVRx, Inc.
DFNDShares1.95M
TypeSH
Market value$10.05M
0.63%
Sole
1.95M
Shared
0.00
None
0.00
Black Diamond Therapeutics, Inc.
DFNDShares4.45M
TypeSH
Market value$8.23M
0.52%
Sole
4.45M
Shared
0.00
None
0.00
Karyopharm Therapeutics Inc.
DFNDShares576.78K
TypeSH
Market value$5.64M
0.35%
Sole
576.78K
Shared
0.00
None
0.00
Inventiva SA
DFNDShares1.46M
TypeSH
Market value$5.53M
0.35%
Sole
1.46M
Shared
0.00
None
0.00
LeonaBio, Inc.
DFNDShares464.40K
TypeSH
Market value$4.27M
0.27%
Sole
464.40K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
DFNDShares3.78M
TypeSH
Market value$4.15M
0.26%
Sole
3.78M
Shared
0.00
None
0.00
Marker Therapeutics, Inc.
DFNDShares1.63M
TypeSH
Market value$2.39M
0.15%
Sole
1.63M
Shared
0.00
None
0.00
OnKure Therapeutics, Inc.
DFNDShares478.55K
TypeSH
Market value$2.18M
0.14%
Sole
478.55K
Shared
0.00
None
0.00
ImageneBio, Inc.
DFNDShares50.01K
TypeSH
Market value$295.0K
0.02%
Sole
50.01K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc.DFND | COM | 13.22M | SH | $246.59M 15.53% | 13.22M | 0.00 | 0.00 |
MBX Biosciences, Inc.DFND | COM | 3.61M | SH | $199.52M 12.56% | 3.61M | 0.00 | 0.00 |
Monte Rosa Therapeutics, Inc.DFND | COM | 7.69M | SH | $186.15M 11.72% | 7.69M | 0.00 | 0.00 |
Celcuity Inc.DFND | COM | 1.71M | SH | $178.96M 11.27% | 1.71M | 0.00 | 0.00 |
Spyglass Pharma, Inc.DFND | COM SHS | 7.39M | SH | $164.55M 10.36% | 7.39M | 0.00 | 0.00 |
Savara, Inc.DFND | COM | 24.47M | SH | $150.74M 9.49% | 24.47M | 0.00 | 0.00 |
Zenas BioPharma, Inc.DFND | COM | 4.02M | SH | $102.11M 6.43% | 4.02M | 0.00 | 0.00 |
Coursera, Inc.DFND | COM | 12.87M | SH | $72.57M 4.57% | 12.87M | 0.00 | 0.00 |
Aurinia Pharmaceuticals, Inc.DFND | COM | 3.97M | SH | $67.37M 4.24% | 3.97M | 0.00 | 0.00 |
CRISPR Therapeutics AGDFND | NAMEN AKT | 1.06M | SH | $57.73M 3.64% | 1.06M | 0.00 | 0.00 |
ORIC Pharmaceuticals, Inc.DFND | COM | 4.12M | SH | $44.60M 2.81% | 4.12M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.DFND | COM | 1.96M | SH | $21.27M 1.34% | 1.96M | 0.00 | 0.00 |
Korro Bio, Inc.DFND | COM | 1.30M | SH | $17.11M 1.08% | 1.30M | 0.00 | 0.00 |
X4 Pharmaceuticals, Inc.DFND | COM | 3.23M | SH | $15.10M 0.95% | 3.23M | 0.00 | 0.00 |
Champions Oncology, Inc.DFND | COM NEW | 1.71M | SH | $10.56M 0.66% | 1.71M | 0.00 | 0.00 |
Nkarta, Inc.DFND | COM | 3.57M | SH | $10.10M 0.64% | 3.57M | 0.00 | 0.00 |
CVRx, Inc.DFND | COM | 1.95M | SH | $10.05M 0.63% | 1.95M | 0.00 | 0.00 |
Black Diamond Therapeutics, Inc.DFND | COM | 4.45M | SH | $8.23M 0.52% | 4.45M | 0.00 | 0.00 |
Karyopharm Therapeutics Inc.DFND | COM NEW | 576.78K | SH | $5.64M 0.35% | 576.78K | 0.00 | 0.00 |
Inventiva SADFND | ADS | 1.46M | SH | $5.53M 0.35% | 1.46M | 0.00 | 0.00 |
LeonaBio, Inc.DFND | COM | 464.40K | SH | $4.27M 0.27% | 464.40K | 0.00 | 0.00 |
Senti Biosciences, Inc.DFND | COM NEW | 3.78M | SH | $4.15M 0.26% | 3.78M | 0.00 | 0.00 |
Marker Therapeutics, Inc.DFND | COM NEW | 1.63M | SH | $2.39M 0.15% | 1.63M | 0.00 | 0.00 |
OnKure Therapeutics, Inc.DFND | COM CL A | 478.55K | SH | $2.18M 0.14% | 478.55K | 0.00 | 0.00 |
ImageneBio, Inc.DFND | COM | 50.01K | SH | $295.0K 0.02% | 50.01K | 0.00 | 0.00 |
Page 1 of 2